ftInvstr
PGHL · Healthcare ₹5653.0 -1.87% Mkt Cap ₹9368 Cr

PGHL

Healthcare Drug Manufacturers - Specialty & Generic
₹5653.0
-1.87% today · 30d -5.78%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for PGHL. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹364 Cr
+7.37% YoY
NET PROFIT
₹96 Cr
+45.29% YoY
OPM
28.15%
+0.62pp YoY
EPS
₹57.92
PE 26.35
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-41.6%, h2=-37.4%, h3=-33.4% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
PGHL26.35
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
67
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation REASONABLE 60
Growth STRONG 83
Profitability HIGH 90
Technicals WEAK 40
Risk LOW 90
Key Stats
TTM PE
26.35
P/B
17.93
52W HIGH
₹6975.0
OFF HIGH
-18.95%
DIV YIELD
2.74%
MKT CAP
₹9368 Cr
◉ Active Signals
MACDNeutral5.8372
RSI(14)Bearish35.1
Street Consensus
1 analyst
₹7090.0
mean target
Low ₹7090.0Now ₹5653.0High ₹7090.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PGHL and at what entry.

Sign up freeSign in